Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China

NCT01647191 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.

NCT NCT01647191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01647191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China
Lead sponsor
Shanghai Mental Health Center
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2011
Completion date
May 31, 2015
Enrollment
240 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c